Poly(glycerol sebacate)-interleukin inhibitor copolymers and methods of making and use
US-2019016854-A1 · Jan 17, 2019 · US
US11866523B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11866523-B2 |
| Application number | US-202117223722-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 6, 2021 |
| Priority date | Apr 6, 2020 |
| Publication date | Jan 9, 2024 |
| Grant date | Jan 9, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A water-mediated process prepares a polymeric (meth)acrylation composition. In some embodiments, the process includes providing a stabilized aqueous solution including a (meth)acrylation component and a polyol monomer in a vessel under an inert atmosphere and adding a diacid monomer to the vessel under the inert atmosphere. In some embodiments, the process includes providing a stabilized aqueous solution including a (meth)acrylation component and a copolymer of a polyol monomer and a diacid monomer in a vessel under an inert atmosphere. The process further includes heating and removing water from the vessel under the inert atmosphere to produce the polymeric (meth)acrylation composition. The polymeric (meth)acrylation composition includes a (meth)acrylation polyester copolymer of the diacid monomer and the polyol monomer with the (meth)acrylation component conjugated to the (meth)acrylation polyester copolymer. In some embodiments, the polymeric (meth)acrylation composition is free of mineral acid and free of cytotoxic solvents, catalysts, and scavengers.
Opening claim text (preview).
What is claimed is: 1. A water-mediated process of preparing a polymeric (meth)acrylation composition, comprising the steps of: providing a stabilized aqueous solution comprising at least one (meth)acrylation component and a polyol monomer in a vessel under an inert atmosphere; adding a diacid monomer to the vessel under the inert atmosphere; and heating and removing water from the vessel under the inert atmosphere to produce the polymeric (meth)acrylation composition; wherein the polymeric (meth)acrylation composition comprises a (meth)acrylation polyester copolymer of the diacid monomer and the polyol monomer with the at least one (meth)acrylation component conjugated to the (meth)acrylation polyester copolymer. 2. The process of claim 1 , wherein the stabilized aqueous solution aids in preventing propagation and initiation of a free radical polymerization of the (meth)acrylate during the combining, the adding; and the heating and removing. 3. The process of claim 1 further comprising degassing an aqueous solution to form the stabilized aqueous solution. 4. The process of claim 1 further comprising adding a free radical stabilizer, a polymerization inhibitor, or a combination thereof to an aqueous solution to form the stabilized aqueous solution. 5. The process of claim 1 , wherein the at least one (meth)acrylation component comprises a (meth)acrylate. 6. The process of claim 1 , wherein the at least one (meth)acrylation component comprises a photoinitiator. 7. The process of claim 6 , wherein the photoinitiator is selected from the group consisting of ethyl eosin, eosin Y, fluorescein, 2,2-dimethoxy, 2-phenylacetophenone, 2-methoxy, 2-phenylacetophenone, camphorquinone, rose bengal, methylene blue, erythrosin, phloxime, thionine, riboflavin, and methylene green. 8. The process of claim 6 , wherein the photoinitiator comprises riboflavin. 9. The process of claim 1 , wherein the at least one (meth)acrylation component comprises a co-initiator. 10. The process of claim 9 , wherein the co-initiator is selected from the group consisting of triethanolamine, triethylamine, ethanolamine, N-methyl diethanolamine, N,N-dimethyl benzylamine, N-benzyl ethanolamine, N-isopropyl benzylamine, tetramethyl ethylenediamine, potassium persulfate, tetramethyl ethylenediamine, lysine, ornithine, histidine, and arginine. 11. The process of claim 9 , wherein the co-initiator comprises arginine. 12. The process of claim 1 , wherein the heating and removing water from the vessel comprises refluxing the at least one (meth)acrylation component, the polyol monomer, the aqueous solution, and the diacid monomer. 13. The process of claim 1 , wherein the polyol monomer comprises glycerol. 14. The process of claim 1 , wherein the diacid monomer comprises sebacic acid. 15. The process of claim 1 , wherein the polymeric (meth)acrylation composition is free of mineral acid and free of cytotoxic solvents, catalysts, and scavengers.
Aqueous solvent · CPC title
with sensitising agents · CPC title
Methyl esters {, e.g. methyl (meth)acrylate} · CPC title
Stable Free Radical Polymerisation [SFRP]; Nitroxide Mediated Polymerisation [NMP] for, e.g. using 2,2,6,6-tetramethylpiperidine-1-oxyl [TEMPO] · CPC title
Polyesters having been prepared in the presence of compounds having one reactive group or more than two reactive groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.